Mumbai, Maharashtra, India, January 2025 – Cipla, a trusted leader in the global pharmaceutical industry, has announced the appointment of Achin Gupta as its Global Chief Operating Officer, effective immediately. With a tenure at Cipla since 2021 as CEO of the One India Business, Achin Gupta has been instrumental in driving transformation, achieving double-digit revenue growth, and solidifying Cipla’s position as a leader in the pharmaceutical sector by volume.
A Proven Leader in Healthcare Transformation
During his tenure, Gupta led Cipla’s One India Business, overseeing branded, generics, consumer health, and digital therapeutics verticals. His leadership propelled Cipla to deepen its presence in chronic therapies, expand operations in Tier 2-6 geographies, and establish category leadership in wellness brands. Additionally, he developed a robust trade generics business and formed strategic alliances with multinational corporations, securing Cipla’s position as a preferred partner for innovation and in-licensing.
Gupta’s patient-centric initiatives, such as Cipla Digital Health and the Retail Task Force, have been recognized for their impact and innovation, furthering Cipla’s purpose-driven approach to healthcare. These efforts have garnered accolades from prestigious forums, emphasizing Cipla’s dedication to transforming healthcare through technology and innovation.
A Stellar Professional Journey
Gupta brings over two decades of experience across global markets, including India, Europe, and emerging economies. His previous roles include:
- Executive Vice President at Glenmark Pharmaceuticals, where he led regional transformations in Europe, the Middle East, Africa, and Latin America.
- Director of Strategic Planning at Abbott Laboratories, spearheading global growth initiatives.
- Senior positions at A.T. Kearney, where he advised leading corporates on strategy and operational improvements.
Gupta holds an M.Tech in Biochemical Engineering and Biotechnology from IIT Delhi and an MBA from IIM Ahmedabad. His entrepreneurial mindset and expertise have been pivotal in launching and scaling businesses worldwide.
About Cipla
Since its inception in 1935, Cipla has been a global leader in pharmaceuticals, renowned for its compassionate approach to healthcare and its commitment to sustainability. Operating in 80+ countries with a portfolio of 1,500+ products across various therapeutic categories, Cipla has consistently prioritized accessibility, affordability, and innovation in healthcare.
Cipla’s legacy includes paradigm-shifting contributions like introducing triple anti-retroviral therapy for HIV/AIDS in Africa at less than a dollar a day, which revolutionized access to treatment globally. Today, Cipla is recognized as a global leader in respiratory care and remains steadfast in its mission to ensure high-quality medicines for patients worldwide
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
